Titan Biotech Share Price

Newspaper publication of the Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2026

• BSE India
• 4 days 15 hours ago

<h3><span style="font-size:16px;"><strong>Specialty Chemicals company Titan Biotech announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> In Q1FY27, the company reported revenue of Rs 5,916.66 lakh, representing a growth of 27.25% compared to Rs 4,649.64 lakh in Q1FY26 (YoY) and an increase of 21.16% from Rs 4,883.35 lakh in Q4FY26 (QoQ).</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> Total income for Q1FY27 stood at Rs 6,097.92 lakh, up 29.14% YoY from Rs 4,721.86 lakh and up 19.71% QoQ from Rs 5,093.99 lakh.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> The company achieved a PBT of Rs 1,273.42 lakh in Q1FY27, reflecting a growth of 56.98% YoY compared to Rs 811.21 lakh and a 23.85% increase from Rs 1,028.17 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit for the Period:</strong> Net profit in Q1FY27 was Rs 1,085.68 lakh, a growth of 58.20% YoY from Rs 686.28 lakh and up 61.34% QoQ from Rs 672.91 lakh.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Annual Performance (FY26):</strong> For the full year ended March 31, 2026, the company recorded a total income of Rs 21,160.05 lakh and a net profit of Rs 2,988.52 lakh.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Earnings Per Share (EPS):</strong> Basic and Diluted EPS for Q1FY27 stood at Rs 2.63, compared to Rs 8.30 in Q1FY26 and Rs 1.63 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Revenue from Operations:</strong> Standalone revenue for Q1FY27 reached Rs 5,916.66 lakh, rising by 27.25% YoY and 21.16% QoQ.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Total Income:</strong> Standalone total income for Q1FY27 was Rs 6,097.92 lakh, an increase of 29.14% YoY and 19.71% QoQ.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Profit Before Tax (PBT):</strong> Standalone PBT for Q1FY27 was Rs 1,273.42 lakh, up 56.98% YoY and 23.85% QoQ.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Net Profit for the Period:</strong> Standalone net profit stood at Rs 945.59 lakh for Q1FY27, showing a significant growth of 53.48% YoY from Rs 616.08 lakh and a 44.24% increase from Rs 655.57 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Annual Performance (FY26):</strong> Standalone total income for FY26 was Rs 21,160.05 lakh with a net profit of Rs 2,744.72 lakh.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Business Highlights</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Segment Performance:</strong> The company operates in only one reportable business segment.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Consolidated Group Structure:</strong> The consolidated financial results for Q1FY27 include the performance of the holding company, Titan Biotech Limited, and its associate companies, Peptech Biosciences Limited and Titan Media Limited.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Freight and GST Treatment:</strong> Freight amounts have been added to the revenue from operations to facilitate the calculation of sales including GST for the current year. To neutralise the impact, an equivalent freight amount has been added to other expenses.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Share in Associates:</strong> The Group’s share in the profit of its associates for Q1FY27 was Rs 140.09 lakh, compared to Rs 70.20 lakh in Q1FY26 and Rs 17.34 lakh in Q4FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5787890/" target="_blank">Result PDF</a></p>

• Trendlyne
• 5 days 11 hours ago

Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 2026

• BSE India
• 5 days 11 hours ago